The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma

British Journal of Haematology

Volumn 165, Issue 1, 2014, Pages 112-116

  Oki, Yasuhiro ^a   Chuang, Hubert ^a   Chasen, Beth ^a   Jessop, Aaron ^a   Pan, Tinsu ^a   Fanale, Michelle ^a   Dabaja, Bouthaina ^a   Fowler, Nathan ^a   Romaguera, Jorge ^a   Fayad, Luis ^a   Hagemeister, Fredrick ^a   Rodriguez, Maria Alma ^a   Neelapu, Sattva ^a   Samaniego, Felipe ^a   Kwak, Larry ^a   Younes, Anas ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Hodgkin lymphoma; Positron emission tomography; Prognostic

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLASSICAL HODGKIN LYMPHOMA; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

HODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSTIC;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84896042967     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12715     Document Type: Article

References (11)

1. Biggi, A., Gallamini, A., Chauvie, S., Hutchings, M., Kostakoglu, L., Gregianin, M., Meignan, M., Malkowski, B., Hofman, M.S. & Barrington, S.F. (2013) International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. Journal of Nuclear Medicine, 54, 683-690.
2. Cerci, J.J., Pracchia, L.F., Linardi, C.C., Pitella, F.A., Delbeke, D., Izaki, M., Trindade, E., Soares, J. Jr, Buccheri, V. & Meneghetti, J.C. (2010) 18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma. Journal of Nuclear Medicine, 51, 1337-1343.
3. Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., Biggi, A., Vitolo, U., Stelitano, C., Sancetta, R., Trentin, L., Luminari, S., Iannitto, E., Viviani, S., Pierri, I. & Levis, A. (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study. Journal of Clinical Oncology, 25, 3746-3752.
4. Hutchings, M., Loft, A., Hansen, M., Pedersen, L.M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.M., Berthelsen, A.K. & Specht, L. (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood, 107, 52-59.
5. Juweid, M.E., Stroobants, S., Hoekstra, O.S., Mottaghy, F.M., Dietlein, M., Guermazi, A., Wiseman, G.A., Kostakoglu, L., Scheidhauer, K., Buck, A., Naumann, R., Spaepen, K., Hicks, R.J., Weber, W.A., Reske, S.N., Schwaiger, M., Schwartz, L.H., Zijlstra, J.M., Siegel, B.A. & Cheson, B.D. & Imaging Subcommittee of International Harmonization Project in, L. (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. Journal of Clinical Oncology, 25, 571-578.
6. Le Roux, P.Y., Gastinne, T., Le Gouill, S., Nowak, E., Bodet-Milin, C., Querellou, S., Mahe, B., Dubruille, V., Blin, N., Salaun, P.Y. & Bodere-Kraeber, F. (2011) Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. European Journal of Nuclear Medicine and Molecular Imaging, 38, 1064-1071.
7. Matloub, Y., Lindemulder, S., Gaynon, P.S., Sather, H., La, M., Broxson, E., Yanofsky, R., Hutchinson, R., Heerema, N.A., Nachman, J., Blake, M., Wells, L.M., Sorrell, A.D., Masterson, M., Kelleher, J.F. & Stork, L.C. (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood, 108, 1165-1173.
8. Meignan, M., Gallamini, A., Meignan, M., Gallamini, A. & Haioun, C. (2009) Report on the First International Workshop on Interim-PET-Scan in Lymphoma. Leukaemia & Lymphoma, 50, 1257-1260.
9. Press, O.W., LeBlanc, M., Rimsza, L.M., Schoder, H., Friedberg, J.W., Evens, A.M., Li, H., Bartlett, N.L., LaCasce, A.S., Sweetenham, J.W., Straus, D.J., Noy, A., Kostakoglul, L., Grewal, R.K., Hsi, E.D., Gascoyne, R.D., Cheson, B.D., Kahl, B.S., Miller, T.P. & Fisher, R.I. (2013) A phase II trial of response-adapted therapy of stages III-IV Hodgkin lymphoma using early interim FDG-PET imaging: US Intergroup S0816. Hematological Oncology, 31 (Suppl 1), abstr 124.
10. Terasawa, T., Lau, J., Bardet, S., Couturier, O., Hotta, T., Hutchings, M., Nihashi, T. & Nagai, H. (2009) Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. Journal of Clinical Oncology, 27, 1906-1914.
11. Zinzani, P.L., Rigacci, L., Stefoni, V., Broccoli, A., Puccini, B., Castagnoli, A., Vaggelli, L., Zanoni, L., Argnani, L., Baccarani, M. & Fanti, S. (2012) Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients. European Journal of Nuclear Medicine and Molecular Imaging, 39, 4-12.